Health Economic Benefits

The use of Nasal High Flow therapy in neonatal and pediatric patients is associated with health and economic benefits.

Evidence Suggests the Use of Nasal High Flow therapy may:

  • Reduce the risk of nasal trauma in neonates1,2,3
    • Clinical studies have shown a 7%-15%2,3 reduction in nasal trauma compared to nCPAP
  • Decrease intubation rates4,5,6,7
  • Reduce clinical deterioration and escalation of therapy4,7,8
  • Reduce PICU length of stay9
  • Reduce PICU admissions and transfers4

What is the Impact?

Evidence indicates that Nasal High Flow therapy may prevent infants requiring therapy escalation and decrease length of stay in intensive care.

 

From the Literature